Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 93, Issue 444, 2004, Pages 29-32

  Subhedar, N V ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Chronic lung disease; Preterm infant; Pulmonary hypertension

Indexed keywords

HYDRALAZINE; ILOPROST; NIFEDIPINE; PROSTACYCLIN DERIVATIVE; VASCULOTROPIN;

ANGIOGENESIS; ARTERIAL OXYGEN SATURATION; CHRONIC LUNG DISEASE; CONFERENCE PAPER; HUMAN; INFANT MORTALITY; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG LAVAGE; LUNG VASCULAR RESISTANCE; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 1242270536     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2004.tb03046.x     Document Type: Conference Paper

References (29)

1. Abman SH, Accurso FJ, Bowman CM. Unsuspected cardiopulmonary abnormalities complicating bronchopulmonary dysplasia. Arch Dis Child 1984; 59: 966-70
2. Gill AB, Weindling AM. Pulmonary artery pressure changes in the very low birthweight infant developing chronic lung disease. Arch Dis Child 1993; 68: 303-7
3. Ascher DP, Rosen P, Null DM, de Lemos RA, Wheller JJ. Systemic to pulmonary collaterals mimicking patent ductus arteriosus in neonates with prolonged ventilatory courses. J Pediatr 1985; 107: 282-4
4. Subhedar NV, Shaw NJ. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2000; 82: F243-7
5. Fitzgerald D, Evans N, Van Asperen P, Henderson-Smart D. Subclinical persisting pulmonary hypertension in chronic neonatal lung disease. Arch Dis Child Fetal Neonatal Ed 1994; 70: F118-22
6. Fouron JC, Le Guennec JC, Villemant D, Perreault G, Davignon A. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 1980; 65: 529-35
7. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988; 112: 67-72
8. Bush A, Busst CM, Knight WB, Hislop AA, Haworth SG, Shinebourne EA. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990; 65; 739-45
9. Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-68
10. Taghizadeh A, Reynolds EO. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol 1976; 82: 241-64
11. Tomashefski JF, Jr, Oppermann HC, Vawter GF, Reid LM. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984; 2: 469-87
12. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998; 53: 81-94
13. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-3
14. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-7
15. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-80
16. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman CM, Wiggins JW, Jr. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985; 75: 80-4
17. Abman SH. Pulmonary hypertension in chronic lung disease of infancy. Pathogenesis, pathophysiology and treatment. In: Bland RD, Coalson JJ, eds. Chronic lung disease of infancy. New York: Marcel Dekker; 2000: 619-68
18. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis". Am J Respir Crit Care Med 2001; 15: 1641755-6
19. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L600-7
20. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001; 164: 1981-7
21. Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment. Arch Dis Child Fetal Neonatal Ed 1995; 72: F14-9
22. Johnson CE, Beekman RH, Kostyshak DA, Nguyen T, Oh DM, Amidon GL. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res 1991; 29: 500-3
23. The STOP_ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295-310
24. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347: 436-40
25. Clark PL, Ekekezie II, Kaftan HA, Castor CA, Truog WE. Safety and efficacy of nitric oxide in chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2002; 86: F41-5
26. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999; 103: 610-8
27. Lonnqvist PA, Jonsson B, Winberg P, Frostell CG. Inhaled nitric oxide in infants with developing or established chronic lung disease. Acta Paediatr 1995; 84: 1188-92
28. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002; 165: 1098-102
29. Oliver J, Webb D. Sildenafil for "blue babies". BMJ 2002; 325: 1174